Evidence map›Paper›PMID 37816832›Full record

ArticleScientific reports2023

Antcin-B, a phytosterol-like compound from Taiwanofungus camphoratus inhibits SARS-CoV-2 3-chymotrypsin-like protease (3CL

Gyaltsen Dakpa, K J Senthil Kumar, Jochem Nelen, Horacio Pérez-Sánchez, Sheng-Yang Wang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Gyaltsen DakpaMolecular and Biological Agricultural Sciences Program, Taiwan International Graduate Program, Academia Sinica, Taipei, 108, Taiwan.
K J Senthil KumarBachelor Program of Biotechnology, National Chung Hsing University, Taichung, 402, Taiwan.
Jochem NelenStructural Bioinformatics and High-Performance Computing Research Group (BIO-HPC), HiTech Innovation Hub, Universidad Católica de Murcia (UCAM), 30107, Murcia, Spain.
Horacio Pérez-SánchezStructural Bioinformatics and High-Performance Computing Research Group (BIO-HPC), HiTech Innovation Hub, Universidad Católica de Murcia (UCAM), 30107, Murcia, Spain.
Sheng-Yang WangMolecular and Biological Agricultural Sciences Program, Taiwan International Graduate Program, Academia Sinica, Taipei, 108, Taiwan. taiwanfir@drgon.nchu.edu.tw.
National Chung Hsing University · TWUniversidad Católica de Murcia · ESInstitute of Molecular Biology, Academia Sinica · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the remarkable development of highly effective vaccines, including mRNA-based vaccines, within a limited timeframe, coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is not been entirely eradicated. Thus, it is crucial to identify new effective anti-3CL

Indexed as

COVID-19VaccinesAntiviral AgentsChymasesHumansMolecular Docking SimulationMolecular Dynamics SimulationPolyporalesProtease InhibitorsSARS-CoV-2Antiviral AgentsChymasesProtease InhibitorsVaccines

Identifiers

PMID37816832
PMCPMC10564890
OpenAlexW4387495751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.